Mindray Medical today's subscription | Top purchase must be equipped with a market value of 360,000 yuan

According to the announcement of the Exchange, Mindray Medical has applied for the purchase of the Shenzhen Stock Exchange today. The company plans to raise 5.934 billion yuan of funds, surpassing the previous fundraising scale of 5.35 billion in the Ningde era, creating a new high in the IPO of the GEM. It is also the single IPO after the Industrial Fulfillment this year.

Mindray Medical plans to issue 121.6 million shares, the purchase code is 300760, and the single account purchase limit is 36,000 shares. The company's issue price is 48.8 yuan, and the price-earnings ratio is 22.99 times. It is the largest in China. medical instruments enterprise Mindray Medical is the second Chinese stock to return through IPO after the drug Mingkang.

On January 25, 1999, the State Administration for Industry and Commerce issued the “Business License for Enterprise Legal Person” established by Mindray Limited. On December 26, 2001, the Shenzhen Administration for Industry and Commerce issued a change to the company. "Corporate Legal Person Business License".

Software development for the production and operation of medical electronic instruments and their supporting reagents and products (excluding national restrictions); self-produced products after-sales service, own house leasing.